Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Oncotarget
|
April 9, 2019
Specific allelic variants of SNPs in the <i>MDM2</i> and <i>MDMX</i> genes are associated with earlier tumor onset and progression in Caucasian breast cancer patients
Marcus Bauer, Eva Johanna Kantelhardt, Thorsten Stiewe, et al.
Breast Cancer Research and Treatment
|
August 17, 2024
Prognostic and predictive impact of NOTCH1 in early breast cancer
Julia Engel, Vanessa Wieder, Marcus Bauer, et al.
Breast Care (Basel, Switzerland)
|
January 27, 2022
Identifying High-Risk Triple-Negative Breast Cancer Patients by Molecular Subtyping
Carolin Hartung, Martin Porsch, Kathrin Stückrath, et al.
Cancers
|
March 11, 2023
Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group
Christoph Thomssen, Martina Vetter, Eva J Kantelhardt, et al.
BMC Cancer
|
February 7, 2014
FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients
Peter A Fasching, Sebastian M Jud, Maik Hauschild, et al.
Archives of Gynecology and Obstetrics
|
June 10, 2017
Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO survey
Evelyn Klein, Matthias W Beckmann, Werner Bader, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 13, 2025
Experiences and expectations of advance directives in gynecological cancer patients (the NOGGO-expression X study)
Melisa Guelhan Inci, Ebru Ilter, Eva Roser, et al.
JAMA Surgery
|
June 7, 2023
Safety of Targeted Axillary Dissection After Neoadjuvant Therapy in Patients With Node-Positive Breast Cancer
Sherko Kuemmel, Joerg Heil, Simona Bruzas, et al.
Annals of Surgery
|
November 6, 2020
A Prospective, Multicenter Registry Study to Evaluate the Clinical Feasibility of Targeted Axillary Dissection (TAD) in Node-positive Breast Cancer Patients
Sherko Kuemmel, Joerg Heil, Anna Rueland, et al.
Geburtshilfe Und Frauenheilkunde
|
February 16, 2022
Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia)
Alexander Hein, Sven Kehl, Lothar Häberle, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Oncotarget
|
April 9, 2019
Specific allelic variants of SNPs in the <i>MDM2</i> and <i>MDMX</i> genes are associated with earlier tumor onset and progression in Caucasian breast cancer patients
Marcus Bauer, Eva Johanna Kantelhardt, Thorsten Stiewe, et al.
Breast Cancer Research and Treatment
|
August 17, 2024
Prognostic and predictive impact of NOTCH1 in early breast cancer
Julia Engel, Vanessa Wieder, Marcus Bauer, et al.
Breast Care (Basel, Switzerland)
|
January 27, 2022
Identifying High-Risk Triple-Negative Breast Cancer Patients by Molecular Subtyping
Carolin Hartung, Martin Porsch, Kathrin Stückrath, et al.
Cancers
|
March 11, 2023
Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group
Christoph Thomssen, Martina Vetter, Eva J Kantelhardt, et al.
BMC Cancer
|
February 7, 2014
FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients
Peter A Fasching, Sebastian M Jud, Maik Hauschild, et al.
Archives of Gynecology and Obstetrics
|
June 10, 2017
Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO survey
Evelyn Klein, Matthias W Beckmann, Werner Bader, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 13, 2025
Experiences and expectations of advance directives in gynecological cancer patients (the NOGGO-expression X study)
Melisa Guelhan Inci, Ebru Ilter, Eva Roser, et al.
JAMA Surgery
|
June 7, 2023
Safety of Targeted Axillary Dissection After Neoadjuvant Therapy in Patients With Node-Positive Breast Cancer
Sherko Kuemmel, Joerg Heil, Simona Bruzas, et al.
Annals of Surgery
|
November 6, 2020
A Prospective, Multicenter Registry Study to Evaluate the Clinical Feasibility of Targeted Axillary Dissection (TAD) in Node-positive Breast Cancer Patients
Sherko Kuemmel, Joerg Heil, Anna Rueland, et al.
Geburtshilfe Und Frauenheilkunde
|
February 16, 2022
Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia)
Alexander Hein, Sven Kehl, Lothar Häberle, et al.
Page
of 5